LT3630092T - Kompozicija, kurios pagrindą sudaro vitaminas e arba jo esteris, skirta bakterijų ir grybelių bioplėvelėms gydyti - Google Patents

Kompozicija, kurios pagrindą sudaro vitaminas e arba jo esteris, skirta bakterijų ir grybelių bioplėvelėms gydyti

Info

Publication number
LT3630092T
LT3630092T LTEPPCT/EP2018/063926T LT18063926T LT3630092T LT 3630092 T LT3630092 T LT 3630092T LT 18063926 T LT18063926 T LT 18063926T LT 3630092 T LT3630092 T LT 3630092T
Authority
LT
Lithuania
Prior art keywords
vitamin
ester
treating bacterial
formulation based
fungal biofilms
Prior art date
Application number
LTEPPCT/EP2018/063926T
Other languages
English (en)
Inventor
Giorgio Panin
Original Assignee
Hulka S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hulka S.R.L. filed Critical Hulka S.R.L.
Publication of LT3630092T publication Critical patent/LT3630092T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicinal Preparation (AREA)
LTEPPCT/EP2018/063926T 2017-05-29 2018-05-28 Kompozicija, kurios pagrindą sudaro vitaminas e arba jo esteris, skirta bakterijų ir grybelių bioplėvelėms gydyti LT3630092T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102017000058311A IT201700058311A1 (it) 2017-05-29 2017-05-29 Formulazione a base di vitamina E o di un suo estere per il trattamento di biofilm batterici e fungini
PCT/EP2018/063926 WO2018219862A1 (en) 2017-05-29 2018-05-28 Formulation based on vitamin e or an ester thereof for treating bacterial and fungal biofilms

Publications (1)

Publication Number Publication Date
LT3630092T true LT3630092T (lt) 2022-06-27

Family

ID=60294053

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2018/063926T LT3630092T (lt) 2017-05-29 2018-05-28 Kompozicija, kurios pagrindą sudaro vitaminas e arba jo esteris, skirta bakterijų ir grybelių bioplėvelėms gydyti

Country Status (22)

Country Link
US (3) US20200360339A1 (lt)
EP (1) EP3630092B1 (lt)
CN (1) CN110650737A (lt)
AU (1) AU2018275487B2 (lt)
BR (1) BR112019023962A8 (lt)
CA (1) CA3061568C (lt)
CL (1) CL2019003254A1 (lt)
DK (1) DK3630092T3 (lt)
EA (1) EA201992190A1 (lt)
ES (1) ES2919423T3 (lt)
GE (1) GEP20207179B (lt)
HR (1) HRP20220808T1 (lt)
HU (1) HUE059185T2 (lt)
IT (1) IT201700058311A1 (lt)
LT (1) LT3630092T (lt)
MA (1) MA48936B1 (lt)
MX (1) MX2019013559A (lt)
PL (1) PL3630092T3 (lt)
PT (1) PT3630092T (lt)
RS (1) RS63347B1 (lt)
SI (1) SI3630092T1 (lt)
WO (1) WO2018219862A1 (lt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201700058311A1 (it) * 2017-05-29 2018-11-29 Bio Lo Ga Srl Formulazione a base di vitamina E o di un suo estere per il trattamento di biofilm batterici e fungini

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3755558A (en) * 1971-02-23 1973-08-28 Du Pont Polylactide drug mixtures for topical application atelet aggregation
JPH09169643A (ja) * 1995-12-22 1997-06-30 Sekisui Chem Co Ltd 寄生性皮膚疾患治療用外用剤
IT1302275B1 (it) * 1998-09-25 2000-09-05 Giorgio Panin Formulazione di gel idrofobo a base di vitamina e acetato perapplicazione topica.
ES2713349T3 (es) * 2009-04-15 2019-05-21 Bmg Pharma S P A Composiciones de sal mineral-ácido sulfónico y procedimientos de uso
ITUB20153889A1 (it) * 2015-09-25 2017-03-25 Bio Lo Ga Srl Gel idrofobico a base di vitamina E esente da prodotti siliconici per applicazione topica
ITUB20169882A1 (it) * 2016-01-08 2017-07-08 Flame S R L Vitamina E per l’uso nel trattamento e nella prevenzione delle infezioni da biofilm.
IT201700058311A1 (it) * 2017-05-29 2018-11-29 Bio Lo Ga Srl Formulazione a base di vitamina E o di un suo estere per il trattamento di biofilm batterici e fungini

Also Published As

Publication number Publication date
US20200121638A1 (en) 2020-04-23
EP3630092A1 (en) 2020-04-08
CA3061568A1 (en) 2018-12-06
US20200360339A1 (en) 2020-11-19
ES2919423T3 (es) 2022-07-26
IT201700058311A1 (it) 2018-11-29
CL2019003254A1 (es) 2020-07-03
US11234958B2 (en) 2022-02-01
MA48936B1 (fr) 2022-08-31
CN110650737A (zh) 2020-01-03
BR112019023962A2 (pt) 2020-06-09
PL3630092T3 (pl) 2022-09-12
HUE059185T2 (hu) 2022-10-28
HRP20220808T1 (hr) 2022-09-30
AU2018275487A1 (en) 2019-11-07
MA48936A (fr) 2020-04-08
GEAP201815201A (lt) 2020-07-27
EA201992190A1 (ru) 2020-09-03
BR112019023962A8 (pt) 2022-07-05
RS63347B1 (sr) 2022-07-29
US20210228541A1 (en) 2021-07-29
GEP20207179B (en) 2020-11-10
AU2018275487B2 (en) 2024-03-14
SI3630092T1 (sl) 2022-08-31
CA3061568C (en) 2024-02-13
MX2019013559A (es) 2022-02-03
EP3630092B1 (en) 2022-04-13
DK3630092T3 (da) 2022-06-20
WO2018219862A1 (en) 2018-12-06
PT3630092T (pt) 2022-06-02

Similar Documents

Publication Publication Date Title
EP3265445A4 (en) Lysyl oxidase-like 2 inhibitors and uses thereof
EP3331530A4 (en) Mthfd2 inhibitors and uses thereof
EP3626383A4 (en) ADDITIONAL PROCESSING HEAD AND PROCESSING MACHINERY
ZA201904798B (en) Microbial compositions and methods
ZA201904120B (en) Microbial compositions and methods
EP3317258A4 (en) LYSYL OXIDASE LIKE 2 INHIBITORS AND USES THEREOF
EP3325462A4 (en) INHIBITORS OF LYSYL OXIDASE-LIKE 2 AND USES OF SAID INHIBITORS
EP3595596A4 (en) TRANSLUMINAL RELEASE DEVICES AND ASSOCIATED KITS AND PROCEDURES
EP3280423A4 (en) Synergistic glycocalyx treatment compositions and methods
EP3383095A4 (en) Multi-user access method and device
EP3322105A4 (en) Beam training method and device for multi-user scenario
EP3448495A4 (en) DEVICES AND METHODS FOR FORMULATION PROCESSING
EP3524853A4 (en) CIRCULATION ELEMENT RETENTION DEVICE AND SPHERICAL SCREW
EP3467078A4 (en) ODOR MODULATOR AND ODOR MODULATION METHOD
EP3299488A4 (en) Carburization device and carburization method
EP3664604A4 (en) HERBICIDAL COMPOSITION AND PROCEDURE
EP3552722A4 (en) LAMINATION PLANT AND LAMINATION METHOD
EP3536719A4 (en) FLUOROPOLYMERS AND RUST PREVENTORS THEREFORE AS AN ACTIVE SUBSTANCE
EP3429488A4 (en) ACCESS AND CORONARY ADMINISTRATION SYSTEMS
EP3432241A4 (en) ADVERTISING SYSTEM AND PROGRAM
EP3276195A4 (en) BEARING DEVICE AND MACHINE
EP3244081A4 (en) Sliding member and sliding bearing
EP3723862A4 (en) OCTASACCHARIDE AND USES THEREOF
HUE059185T2 (hu) Készítmény, amely e vitaminon vagy észteren alapul bakteriális vagy gomba eredetû biofilmek kezelésére
EP3638287A4 (en) METHODS AND COMPOSITIONS FOR TREATING MICROBIAL INFLAMMATION